RT Journal Article
SR Electronic
T1 CoAI: Cost-Aware Artificial Intelligence for Health Care
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.19.21249356
DO 10.1101/2021.01.19.21249356
A1 Erion, Gabriel
A1 Janizek, Joseph D.
A1 Hudelson, Carly
A1 Utarnachitt, Richard B.
A1 McCoy, Andrew M.
A1 Sayre, Michael R.
A1 White, Nathan J.
A1 Lee, Su-In
YR 2021
UL http://medrxiv.org/content/early/2021/01/20/2021.01.19.21249356.abstract
AB The recent emergence of accurate artificial intelligence (AI) models for disease diagnosis raises the possibility that AI-based clinical decision support could substantially lower the workload of healthcare providers. However, for this to occur, the input data to an AI predictive model, i.e., the patient’s features, must themselves be low-cost, that is, efficient, inexpensive, or low-effort to acquire. When time or financial resources for gathering data are limited, as in emergency or critical care medicine, modern high-accuracy AI models that use thousands of patient features are likely impractical. To address this problem, we developed the CoAI (Cost-aware AI) framework to enable any kind of AI predictive model (e.g., deep neural networks, tree ensemble models, etc.) to make accurate predictions given a small number of low-cost features. We show that CoAI dramatically reduces the cost of predicting prehospital acute traumatic coagulopathy, intensive care mortality, and outpatient mortality relative to existing risk scores, while improving prediction accuracy. It also outperforms existing state-of-the-art cost-sensitive prediction approaches in terms of predictive performance, model cost, and training time. Extrapolating these results to all trauma patients in the United States shows that, at a fixed false positive rate, CoAI could alert providers of tens of thousands more dangerous events than other risk scores while reducing providers’ data-gathering time by about 90 percent, leading to a savings of 200,000 cumulative hours per year across all providers. We extrapolate similar increases in clinical utility for CoAI in intensive care. These benefits stem from several unique strengths: First, CoAI uses axiomatic feature attribution methods that enable precise estimation of feature importance. Second, CoAI is model-agnostic, allowing users to choose the predictive model that performs the best for the prediction task and data at hand. Finally, unlike many existing methods, CoAI finds high-performance models within a given budget without any tuning of the cost-vs-performance tradeoff. We believe CoAI will dramatically improve patient care in the domains of medicine in which predictions need to be made with limited time and resources.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the National Science Foundation [CAREER DBI-1552309, and DBI-1759487], American Cancer Society [127332-RSG-15-097-01-TBG], and National Institutes of Health [F30 HL 151074, R35 GM 128638, and R01 NIA AG 061132].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The survey data for this study was gathered under an exempt determination from the University of Washington Institutional Review Board (Human Subjects Division, STUDY00006890).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesOf our three datasets, the ICU and outpatient datasets are publicly available. The ICU dataset is available from the MIT eICU Collaborative Research Database but requires approval before download. The outpatient dataset is a subset of the NHANES I study. It is also uploaded to our Github repository along with our code. The trauma dataset is not publicly available due to patient privacy concerns. https://eicu-crd.mit.edu/gettingstarted/overview/ https://github.com/suinleelab/coai